Cyclic nucleotide phosphodiesterases (
PDEs) regulate the intracellular concentrations and effects of
adenosine 3',5'-cyclic monophosphate (cAMP) and
guanosine 3',5'-cyclic monophosphate (cGMP). The role of
PDEs in malignant
tumor cells is still uncertain. The role of
PDEs, especially PDE2, in human
malignant melanoma PMP cell line was examined in this study. In PMP cells,
8-bromo-cAMP, a cAMP analog, inhibited cell growth and invasion. However,
8-bromo-cGMP, a cGMP analog, had little or no effect. PDE2 and PDE4, but not PDE3, were expressed in PMP cells. Growth and invasion of PMP cells were inhibited by erythro-9-(2-hydroxy-3-nonyl)
adenine (
EHNA), a specific PDE2 inhibitor, but not by
rolipram, a specific
PDE4 inhibitor. Moreover, cell growth and invasion were inhibited by transfection of small interfering RNAs (siRNAs) specific for PDE2A and a catalytically-dead mutant of PDE2A. After treating cells with
EHNA or
rolipram, intracellular cAMP concentrations were increased. Growth and invasion were stimulated by PKA14-22, a
PKA inhibitor, and inhibited by N(6)-benzoyl-c
AMP, a PKA specific cAMP analog, whereas 8-(4-chlorophenylthio)-2'-O-methyl-cAMP, an
Epac specific cAMP analog, did not. Invasion, but not growth, was stimulated by A-
kinase anchor
protein (AKAP) St-Ht31 inhibitory
peptide. Based on these results, PDE2 appears to play an important role in growth and invasion of the human
malignant melanoma PMP cell line. Selectively suppressing PDE2 might possibly inhibit growth and invasion of other malignant tumor cell lines.